D-0481-2017 Class II Terminated

Recalled by Sandoz Inc — Princeton, NJ

FDA drug recall D-0481-2017 was initiated by Sandoz Inc on Feb 2, 2017 and is designated Class II. Reason for recall: Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not cut the patch". The pouch… The recall status is terminated (terminated Oct 24, 2017). Affected quantity: 157,922 cartons.

Recall details

Product Type
Drugs
Report Date
Mar 1, 2017
Initiation Date
Feb 2, 2017
Termination Date
Oct 24, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
157,922 cartons

Product description

Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 1 patch per pouch (NDC 66758-208-58), packaged in 4-count patches per carton (NDC 66758-208-54), Rx Only, Manufactured by ALZA Corporation, Vacaville, CA 95688 for Sandoz Inc., Princeton, NJ 08540.

Reason for recall

Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not cut the patch". The pouch containing the patch is labeled correctly.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot #: 6323Q11, 6328Q11, Exp 06/19; 6355Q11, Exp 07/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0481-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0481-2017. Report a data issue: hello@regdatalab.com.